Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The contents of the presentation may be modified, but the Psychopharmacology Institute logo must remain visible in all slides.

Cardiovascular Effects of ADHD Drugs Scott R. Beach, M.D. Attending Psychiatrist, Massachusetts General Hospital Assistant Professor of Psychiatry, Harvard Medical School

Stimulants Recommendation against using stimulants in patients with serious cardiac problems  No strong evidence for an association of stimulants with elevated risk of serious cardiac events Schelleman, H., Bilker, W. B., Kimmel, S. E., Daniel, G. W., Newcomb, C., Guevara, J. P., ... & Hennessy, S. (2013). Amphetamines, atomoxetine and the risk of serious cardiovascular events in adults. PLoS One, 8(1), e52991.

Key Points Stimulants tend to have cardiac effects that are generally not clinically significant. The FDA continues to recommend against using stimulants in patients with serious cardiac problems.